Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives

A number of 3-substituted-2-(substituted-phenoxymethyl) quinazolin-4(3H)-one derivatives 4a,b, 5a-c, 6, 7a-f, 8a-e and 9a,b have been synthesized. Their structures have been elucidated on the basis of elemental analyses and spectroscopic studies (IR, 1H-NMR, MS). A preliminary evaluation of the anticonvulsant activity of the prepared compounds has indicated that compounds 4b, 7b-f, 8a and 9b exhibit significant anticonvulsant activity, while compounds 6, 8b and 8d show mild to moderate activity.     

4,4’-二氯二苯酮合成二氮杂萘联苯酮结构聚醚砜酮的研究

以4-(4-羟基苯基)*2,3-二氮杂萘-1-酮(DHPZ)、4,4’-二氯二苯砜(DCS)和4,4’-二氯二苯酮(DCK)为原料,采用分步加料的方法,合成了系列高分子量的聚芳醚砜酮共聚物(PPESKs),其特性黏度在0.40 ～0.61dL/g之间,解决了由于DCK活性低不适合用于聚芳醚合成的问题.采用FTIR、示差...     

Formation of 3-[amino(aryl)-methylidene]-1,3-dihydro-2H-indol-2-ones involving ring transformation of 2-aryl-5-(2-aminophenyl)-4-hydroxy-1,3-thiazoles

The reaction of 3-bromooxindole with substituted (hetero)aromatic thioamides in acetonitrile was studied. At room temperature the reaction preferably gives products of ring transformation i.e. 2-aryl-5-(2-aminophenyl)-4-hydroxy-1,3-thiazoles (3b-f,h) whereas at elevated temperature products of an Eschenmoser coupling reaction, i.e. 3-[amino(aryl)-methylidene]-1,3-dihydro-2H-indol-2-ones (2b-f), are formed exclusively. There exist only two exceptions (4-methoxy and 2-pyridinthioamide) in which the Eschenmoser coupling reaction always takes place giving 2a and 2g. Also N-methylation of the starting 3-bromooxindole completely prevents formation of thiazoles. The prepared thiazoles 3b-f are unstable in solution and they undergo slow ring transformation to 2b-f. The rate limiting step of this rearrangement involves cleavage of an intermediary thiirane ring, which is slowed down by electron-withdrawing substituents on the thioamide (ρ = ?1.15).     

Computational Studies and Drug Design for HIV-1 Reverse Transcriptase Inhibitors of 3′,4′-di-O-(S)-camphanoyl-(+)-cis-Khellactone (DCK) Analogs

Molecular docking and molecular dynamics simulation were applied to study the binding mode of 3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs anti-HIV inhibitors with HIV-1 RT. The results suggest that there is a strong hydrogen bond between DCK O16 and NH of Lys101, and that DCK analogues might act similarly as other types of HIV-1 RT inhibitors. The investigation about drug resistance for DCK shows no remarkable influence on the most frequently observed mutation K103N of HIV-1 RT. Based on the proposed mechanism, some new structures were designed and predicted by a SVM model. All compounds exhibited potent inhibitory activities against HIV replication in H9 lymphocytes with EC50 values lower than 1.95 microM. The rationality of the method was validated by experimental results.     

Struktur eines homoleptischen Bis-xylitolato(5–)-dicobaltats(III)

Polyol Metal Complexes. 33 [1] Structure of a Homoleptic Bis-xylitolato(5–) Dicobaltate(III) Dark-green crystals of Li₅[Co(LH_–5)₂]Cl · 8 H₂O ( 1 ) (L = Xylitol) are obtained from cobalt(II) and xylitol in alkaline aqueous solution by oxidation with air. In the homoleptic binuclear dicobaltate(iii) ions, the O₁₀ set of an edge-shared Co₂O₁₀ dioctahedron is provided by two entirely deprotonated xylitol ligands.     

Molecular rearrangements of (-)-modhephene and (-)-isocomene to a (-)-triquinane

The preparation and further rearrangement of (-)-modhephene (1) to a (-)-triquinane 5 has been assessed through acid catalysis. The rearrangement involved protonation, 1,2 sigma-bond and methyl shifts, and deprotonation. Monitored experiments by 1H NMR spectroscopy suggested the intermediate (-)-isocomene (3), which was further evidenced when a sample of natural (-)-3 undergoes acid-catalyzed conversion to the (-)-triquinane 5. In addition, deuterated (-)-modhephene (1-d) labeled stereospecifically at the 14beta geminal methyl group at C4 was synthesized, through the corresponding chiral deuterated primary alcohol, in 5 steps, starting from natural (-)-14-hydroxymodhephene (8), and rearranged under acid catalysis to elucidate the stereochemical factors that control the methyl shift at this position. The final deuterium-labeled (-)-triquinane, 5-d, obtained from [14-(2)H1]-1-d was established to have deuterium in the methyl group at C5 by 13C NMR spectroscopy. This stereoselective methyl migration is in accordance with the molecular orbital demand formulated by the quantum chemical calculations performed in the present study.     

Synthesis of (-)-7-epiaustraline and (-)-1-epicastanospermine

Highly efficient and selective syntheses of the title compounds are described. The cornerstone of the synthetic plan is the tandem inter [4 + 2]/inter [3 + 2] cycloaddition process. These syntheses differ from previous applications of this strategy in that they incorporate an alkylation in the hydrogenolysis step to close the second ring of the azabicyclic systems. Notable features of the sequence are (1) the highly regio- and stereoselective [3 + 2] cycloaddition of nitronate 15 with siloxymethyl (Z)-beta-silylvinyl ketone (Z)-22b and (2) the highly selective reduction of the resulting ketone 24a with L-Selectride. A single-crystal X-ray structure analysis of synthetic (-)-7-epiaustraline confirmed that the targeted structure was successfully synthesized. This stimulated a reexamination of the structural assignment of the natural product. (-)-1-Epicastanospermine was synthesized in four steps from the common intermediate 27a. The absolute configuration of (-)-1-epicastanospermine was assured by single-crystal X-ray structure analysis of intermediate (-)-27a. Thus, the sign of the optical rotation had to be revised. The overall efficiency of these syntheses were 9 steps and 23% yield for (-)-7-epiaustraline and 10 steps and 20% yield for (-)-1-epicastanospermine     

Total syntheses of beta-carboline alkaloids, (R)-(-)-pyridindolol K1, (R)-(-)-pyridindolol K2, and (R)-(-)-pyridindolol.

The total syntheses of beta-carboline alkaloids, (R)-(-)-pyridindolols (1, 5, and 6) are described. The two key steps involved are (1) a thermal electrocyclic reaction of the 3-alkenylindole-2-aldoxime 10 and (2) a thermal cyclization of 3-alkynylindole-2-aldoxime 11 to construct the beta-carboline N-oxides 8, which upon heating with acetic anhydride and sequential treatment with trifluoromethanesulfonic anhydride gave the triflates 18. The Stille coupling reaction of 18 with vinylstannane, followed by cleavage of MOM ether, afforded the 1-ethenyl-3-hydroxymethyl-beta-carboline (7a). Subsequent acetylation of 7a yielded the acetate 7b, which was subjected to the Sharpless asymmetric 1,2-dihydroxylation by AD-mix-beta to produce (R)-(-)-pyridindolol K2 (6). Selective acetylation of 6 was effected by Ac(2)O and collidine to form (R)-(-)-pyridindolol K1 (5). By contrast, hydrolysis of 6 provided (R)-(-)-pyridindolol (1).     

Reaction of (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) with guanosine

The reaction of a new antitumor platinum complex, (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato++ +)platinum(II) (1) with guanosine at room temperature in an aqueous solution was followed by proton nuclear magnetic resonance (1H-NMR) spectroscopy and high performance liquid chromatography (HPLC) at intervals. Both techniques showed that a new compound was formed by displacement of the 1,1-cyclobutanedicarboxylate moiety of 1 with two guanosines, and its 1H-NMR spectrum and HPLC chromatogram were proved to be identical with those of [(R)-(-)-2-aminomethylpyrrolidine]bis(N7-guanosine)platinum(II) (2), which was obtained upon successive treatment of (R)-(-)-2-aminomethylpyrrolidinedichloroplatinum(II) (3) with AgNO3 and 2 mol eq of guanosine in water. The binding sites of the platinum to the two guanosine moieties in 2 were confirmed by the pH dependence of the two G-H8 signals.     

Total synthesis of (S)-(+)-curcudiol, and (S)-(+)- and (R)-(-)-curcuphenol.

A highly enantioselective synthesis of the versatile chiral synthons possessing one stereogenic center, (S)- and (R)-4-aryl-5-hydroxy-(2E)-pentenoate (3) was achieved based on the enzymatic reaction of (+/-)-3 with commercially available lipases MY-30 or OF-360 from Candida rugosa. Application of (S)-3 and (R)-3 to the total syntheses of(S)-curcuphenol (1), (S)-curcudiol (2), and (R)-curcuphenol (1), respectively, is described.     

Mechanistic Investigation into the Unique Orientation Textures of Poly(vinylidene fluoride) in Blends with Nylon 11

Self‐seeded crystallization experiments were carried out to detect the mechanism of the unique orientation behavior of poly(vinylidene fluoride) (PVDF) in oriented PVDF/nylon 11 blends. It was found that primary nuclei have no effects on the final orientation textures adopted by PVDF. The results show that the PVDF crystal orientation in the oriented blends is determined in the early stage of crystal growth, thus a trans crystallization mechanism is preferred.

Isothermal crystallization kinetics for the self‐seeded and non‐self‐seeded crystallization at 145 °C.     

Synthesis of some 2-substituted pyrrolidine alkaloid analogues: N-benzyl-2-(5-substituted 1,3,4-oxadiazolyl) pyrrolidine derivatives and pharmacological screening

Six of N-benzyl-2-(5-substituted 1,3,4-oxadiazolyl) pyrrolidine derivatives 5(a-f) were synthesized from l-proline and characterized by IR, 1H NMR, 13C NMR, and GC–MS. All compounds were tested for antioxidant activity in vitro by the DPPH method. The decrease in absorption of the reaction mixture is considered to have strong antioxidant activity. Among the composites (2, 3, the 5 (b-f)) which bear N-benzyl-2-(5-substituted 1,3,4-oxadiazolyl) pyrrolidine moieties are the most active because they contain donor groups: -Ph-(p-NH₂); -Ph-(p-F); -Ph-(p-Cl); N-Bz-Pyrrolidyl-. Antibacterial activities of the synthetic compounds assessed using the paper disk diffusion and broth dilution methods against Gram-negative bacteria: Escherichia coli ATCC 25922, Pseudomonas aerugenosa ATCC 27853 and Gram-positive bacteria, Staphylococcus aureus ATCC25923, Enterococcus faecalis (ATCC-29212) derived from ATCC 11778 and they showed a variable effect. Gentamycin was used as a positive reference.     

相转移催化法合成反式-3，4，5-三甲氧基-4′-硝基二苯乙烯

以3,4,5-三甲氧基苯甲醛和对硝基甲苯为原料,利用相转移催化法经缩合脱水合成了反式-3,4,5-三甲氧基-4′-硝基二苯乙烯。其结构经1H NMR,13C NMR,IR和元素分析确定。以苄基三乙基氯化铵为相转移催化剂时,在室温下反应12 h,产率89%。     

相转移催化法合成反式-3,4,5-三甲氧基-4''''-硝基二苯乙烯

以3,4,5-三甲氧基苯甲醛和对硝基甲苯为原料,利用相转移催化法经缩合脱水合成了反式-3,4,5-三甲氧基-4'-硝基二苯乙烯.其结构经1H NMR,13C NMR,IR和元素分析确定.以苄基三乙基氯化铵为相转移催化剂时,在室温下反应12 h,产率89%.     

Reversed-phase ion-pair high performance liquid chromatographic determination of Co(III)-, Ni(II)-, V(V)- and Fe(III)-2-(2-benzothiazolylazo)-5-(3-sulforpropyl)aminophenol chelates

The separation and determination of Co(III), Ni(II), V(V) and Fe(III) chelates with 2-(2-benzothiazolylazo)-5-(3-sulfopropyl)aminophenol (BTASPAP) by reversed-phase ion-pair HPLC was investigated. In the presence of the oxidant potassium iodate, BTASPAP reacts with Co(III), Ni(II), V(V) and Fe(III) to form stable, negatively charged, water-soluble chelates. The chelates were separated on a C(18) siloxane bonded phase and eluted within 7 min with acetonitrile-acetate-water (36:1:63 v/v) containing 0.2 mol 1(-1) acetic acid-sodium acetate buffer (pH 3.0) and 1.0 mmol 1(-1) tetrabutylammonium bromide. The detection limits of Co(III), Ni(II), V(V) and Fe(III) at 565 nm are 0.3, 0.8, 0.3 and 1.0 ng (signal-to-noise ratio = 2), respectively. The method was applied to the determination of Co, Ni, V and Fe in four samples of standard alloys.     

2-溴甲基-3-(二溴甲基)喹喔啉的合成研究

以2，3－二（溴甲基）喹喔啉为原料，以N－溴琥珀酰亚胺为溴化试剂合成了2－溴甲基－3－（二溴甲基）喹喔啉（1），1是Diels-Alder环加成反应中形成含杂原子环的C60衍生物的一种重要中间体。通过IR，^1H NMR,^13C NMR,DEPT谱和MS对其进行了结构表征。     

An Efficient Synthesis of Optically Pure (R)- and (S)-2-(aminomethyl)alanine ((R)- and (S)-ama) and (R)- and (S)-2-(aminomethyl)leucine ((R)- and (S)-aml)

An efficient synthesis of enantiomerically pure (R)- and (S)-2-(aminomethyl)alanine ((R)- and (S)-Ama) 1a and (R)- and (S)-2-(aminomethyl)leucine ((R)- and (S)-Aml) 1b is described (Schemes 1 and 2). Resolution of the racemic amino acids was achieved using L -phenylalanine cyclohexylamide ( 2 ) as chiral auxiliary. The free amino acids 1a, b were converted to the N^α-Boc,N^γ-Z-protected derivatives 11a, b (Scheme 3) ready for incorporation into peptides. Based on the three crystal structures of the diastereoisomeric peptides 8a, 8b , and 9b , the absolute configurations in both series were determined. β-Turn type-I geometries were observed for structures 8b and 9b , whereas 8a crystallized in an extended backbone conformation.     

反相高效液相色谱法测定1-(对偶氮苯)-3-(5-氯-2-吡啶)-三氮烯

采用ZORBAX Ec lipse XDB-C8(4.6 mm i.d.×150 mm,5μm)色谱柱,乙腈流动相,流速0.70 mL.m in-1,检测波长407 nm,建立了测定1-(对偶氮苯)-3-(5-氯-2-吡啶)-三氮烯的反相高效液相色谱法.该方法线性范围0.5-8.0 mg.L-1,相对标准偏差为2.5%(c=5.0 mg.L-1,n=5),回收率在95.7%-105%之间.     

Facile one pot multicomponent synthesis of novel 4-(benzofuran-2-yl)-2-(3-(aryl/heteryl)-5-(aryl/heteryl)-4,5-dihydro-1H-pyrazol-1yl)thiazole derivatives

An efficient base catalyzed one pot multicomponent reaction of aryl/hetryl chalcones, thiosemicarbazide and 1-(benzofuran-2-yl)-2-bromoethan-1-one was developed to synthesize the novel 4-(benzofuran-2-yl)-2-(3-(aryl/heteryl)-5-(aryl/heteryl)-4,5-dihydro-1H-pyrazol-1yl)thiazole derivatives.     

5-羟基色胺受体激动剂(1R,2S)-(-)-2-(2-羟基苯基)-N,N-二丙基环丙胺的不对称合成

利用手性双唑啉与三氟甲磺酸亚铜催化2-甲氧基苯乙烯与重氮乙酸二环己基甲酯的不对称环丙烷化反应合成了手性环丙烷羧酸酯,用氢氧化钠对其进行选择性水解得到全反式环丙烷羧酸,其ee值经GC测定为88%.进一步经过Curtius重排、烷基化等反应及重结晶等步骤合成了光学纯的具有生理活性的环丙胺化合物1a和1b.